Tigermed Executes RMB 824.32 Million A-Share Buyback in June; Treasury Stock Climbs to 3.64 % of Capital

Bulletin Express16:57

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has filed its Monthly Return for the period ended 30 June 2026, highlighting a sizeable A-share repurchase and confirming continued compliance with Hong Kong’s public-float rules.

TIGERMED bought back 20.96 million A-shares on the Shenzhen Stock Exchange between 10 and 25 June 2026 at prices ranging from RMB 38.74 to RMB 42.65 per share. The total cash consideration reached approximately RMB 824.32 million, implying an average repurchase price of about RMB 39.33 per share.

As a result of these transactions: • Outstanding A-shares (excluding treasury) fell 2.86 % month-on-month to 711.05 million. • Treasury A-shares expanded from 5.88 million to 26.85 million, now representing 3.64 % of the 737.90 million issued A-shares. • Combined with 123.12 million H-shares (unchanged during the month and with no treasury stock), TIGERMED’s total shares in issue, excluding treasury, stand at approximately 834.18 million.

Authorised and registered share capital remained unchanged at 861.03 million shares (par value: RMB 1 each). The company reported no new share issues, options, warrants, convertibles, or other equity instruments during the month.

TIGERMED confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 5 % requirement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128836744?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 16:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128836744","market":"hk","top_or_hot":-1,"title":"Tigermed Executes RMB 824.32 Million A-Share Buyback in June; Treasury Stock Climbs to 3.64 % of Capital","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has filed its Monthly Return for the period ended 30 June 2026, highlighting a sizeable A-share repurchase and confirming continued compliance with Hong Kong’s public-float rules.</p>\n<p>TIGERMED bought back 20.96 million A-shares on the Shenzhen Stock Exchange between 10 and 25 June 2026 at prices ranging from RMB 38.74 to RMB 42.65 per share. The total cash consideration reached approximately RMB 824.32 million, implying an average repurchase price of about RMB 39.33 per share.</p>\n<p>As a result of these transactions:\n• Outstanding A-shares (excluding treasury) fell 2.86 % month-on-month to 711.05 million.  \n• Treasury A-shares expanded from 5.88 million to 26.85 million, now representing 3.64 % of the 737.90 million issued A-shares.  \n• Combined with 123.12 million H-shares (unchanged during the month and with no treasury stock), TIGERMED’s total shares in issue, excluding treasury, stand at approximately 834.18 million.</p>\n<p>Authorised and registered share capital remained unchanged at 861.03 million shares (par value: RMB 1 each). The company reported no new share issues, options, warrants, convertibles, or other equity instruments during the month.</p>\n<p>TIGERMED confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 5 % requirement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed Executes RMB 824.32 Million A-Share Buyback in June; Treasury Stock Climbs to 3.64 % of Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed Executes RMB 824.32 Million A-Share Buyback in June; Treasury Stock Climbs to 3.64 % of Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-06 16:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has filed its Monthly Return for the period ended 30 June 2026, highlighting a sizeable A-share repurchase and confirming continued compliance with Hong Kong’s public-float rules.</p>\n<p>TIGERMED bought back 20.96 million A-shares on the Shenzhen Stock Exchange between 10 and 25 June 2026 at prices ranging from RMB 38.74 to RMB 42.65 per share. The total cash consideration reached approximately RMB 824.32 million, implying an average repurchase price of about RMB 39.33 per share.</p>\n<p>As a result of these transactions:\n• Outstanding A-shares (excluding treasury) fell 2.86 % month-on-month to 711.05 million.  \n• Treasury A-shares expanded from 5.88 million to 26.85 million, now representing 3.64 % of the 737.90 million issued A-shares.  \n• Combined with 123.12 million H-shares (unchanged during the month and with no treasury stock), TIGERMED’s total shares in issue, excluding treasury, stand at approximately 834.18 million.</p>\n<p>Authorised and registered share capital remained unchanged at 861.03 million shares (par value: RMB 1 each). The company reported no new share issues, options, warrants, convertibles, or other equity instruments during the month.</p>\n<p>TIGERMED confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 5 % requirement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1128836744","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128836744","pubTimestamp":1783328276,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has filed its Monthly Return for the period ended 30 June 2026, highlighting a sizeable A-share repurchase and confirming continued compliance with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药6月执行8.2432亿元A股回购；库存股占资本比例攀升至3.64%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has filed its Monthly Return for the period ended 30 June 2026, highlighting a sizeable A-share repurchase and confirming continued compliance with Hong Kong’s public-float rules.\nTIGERMED bought back 20.96 million A-shares on the Shenzhen Stock Exchange between 10 and 25 June 2026 at prices ranging from RMB 38.74 to RMB 42.65 per share. The total cash consideration reached approximately RMB 824.32 million, implying an average repurchase price of about RMB 39.33 per share.\nAs a result of these transactions:\n• Outstanding A-shares (excluding treasury) fell 2.86 % month-on-month to 711.05 million.  \n• Treasury A-shares expanded from 5.88 million to 26.85 million, now representing 3.64 % of the 737.90 million issued A-shares.  \n• Combined with 123.12 million H-shares (unchanged during the month and with no treasury stock), TIGERMED’s total shares in issue, excluding treasury, stand at approximately 834.18 million.\nAuthorised and registered share capital remained unchanged at 861.03 million shares (par value: RMB 1 each). The company reported no new share issues, options, warrants, convertibles, or other equity instruments during the month.\nTIGERMED confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 5 % requirement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128836744","isCrawlerRequest":true}